ERBB3 expression has been discovered to be upregulated in numerous types of tumors, including but not limited to breast, ovarian, lung, colon, pancreatic, melanoma, gastric, head and neck, and prostate cancers (100–105). This evidence concerns the gene ERBB3 and prostate carcinoma.